Continuous glucose monitors (CGM): how they work and who uses them
A continuous glucose monitor shows glucose readings and trends throughout the day and night. This guide explains the parts, types, benefits and limitations.
Educational information only, not medical advice. Always ask a qualified doctor about your own health. In an emergency call 112 (India) or 911 (US). Read the full disclaimer.
On this page
A continuous glucose monitor, or CGM, is a device that estimates your blood glucose automatically through the day and night. Many people find it gives them a fuller picture than finger-prick checks alone. This article explains the basics based on the NIDDK, with related points from the NHS. A doctor decides whether a CGM is suitable for you.
What is a CGM?
The NIDDK explains that a CGM automatically estimates blood glucose around the clock. Users can check their level at any time and review trends over hours or days.
How does it work?
The NIDDK describes three parts:
- Sensor: a small, disposable device worn under the skin, usually on the belly or arm, that measures glucose in the fluid between cells. Some sensors are implanted instead.
- Transmitter: sends readings wirelessly to a receiver or app.
- Software: runs on a smartphone, an insulin pump or a separate receiver to show the data.
Types of CGM
The NIDDK lists three kinds:
- Real-time: readings are sent and displayed automatically.
- Intermittent-scan: records continuously, but you need to scan the device every few hours to see and store data.
- Doctor-download: collects data for a clinician to review later and is worn for a limited time.
Models differ in where the sensor is worn, how often it is replaced, warm-up time and how settings are adjusted. Some need finger-stick calibration. The NHS refers to continuous or flash glucose monitors in its advice on preventing low blood sugar and ketoacidosis.
Who uses a CGM?
The NIDDK says CGMs are used by people who need insulin for type 1 diabetes, type 2 diabetes or another form of diabetes. Adults and children can use them, and some models are approved for children as young as 2. Use may be continuous or limited to a few days, depending on the doctor's advice.
Possible benefits
Compared with a standard meter, the NIDDK says a CGM may provide:
- Better daily glucose management
- Fewer low blood glucose emergencies
- Fewer finger sticks
- Alerts and trend graphics showing how fast levels are rising or falling
The NIDDK says the greatest benefit comes from daily or near-daily use. It also says a CGM can sound an alarm when glucose drops, which is especially useful for people with hypoglycemia unawareness or frequent lows. The NHS says that for people with type 1 diabetes, a CGM can reduce finger-prick tests.
Limitations to know about
- Finger-stick checks may still be needed to confirm accuracy, especially before changing an insulin dose or acting on a warning alert, according to the NIDDK.
- Disposable sensors typically last 7 to 14 days, and some implantable sensors last up to 180 days. Transmitters may need replacing and devices sometimes need reconnecting.
- Skin redness or irritation from the adhesive patch can occur.
- A CGM costs more than a standard meter, although insurance may cover it.
What is time in range?
The NIDDK's managing diabetes page describes "time in range" as a CGM measure. For many adults, it describes 70 to 180 mg/dL as the range, with a goal of spending at least 70% of the time in it. The NHS describes aiming for about 70% of time in range for people with type 1 diabetes. These targets can differ for each person, for example if you are older, have heart disease or often have lows, so agree your own targets with your care team.
When to see a doctor
Ask your doctor or diabetes team whether a CGM may suit you, how long to use it and how to handle skin problems. Check coverage with your insurer or health service. Do not change insulin or other medicine based only on a sensor reading without following your care team's advice.
Seek urgent help for signs of severe low or very high glucose, such as confusion, fainting, fruity-smelling breath or trouble breathing. In an emergency, call your local emergency number (112 in India, 911 in the United States).
This article is for education only and does not replace advice from your own doctor.
Common questions
What is a continuous glucose monitor?
The NIDDK says it is a device that automatically estimates blood glucose day and night using a sensor worn under the skin.
Does a CGM replace finger-stick tests?
Not always. The NIDDK says finger-stick checks may still be needed to confirm accuracy, especially before changing insulin doses or responding to a warning alert.
How long does a CGM sensor last?
The NIDDK says disposable sensors typically last 7 to 14 days, and some implantable sensors last up to 180 days.
Who can use a CGM?
The NIDDK says people who need insulin for type 1, type 2 or other forms of diabetes can use one, and some models are approved for children as young as 2. A doctor advises.
Important: please read
- Educational information only. This article is general health education. It is not medical advice, diagnosis or treatment. Reading it does not create a doctor–patient relationship with MyDoctor or with anyone else.
- Ask a qualified doctor. Always talk to a qualified, registered doctor about your own health. In India, that means a doctor registered with the National Medical Commission (NMC) or a State Medical Council. In the United States, a licensed physician. Elsewhere, a doctor licensed where you live.
- Never ignore or delay professional advice because of something you read here. Do not start, stop or change any medicine or treatment without your doctor.
- Emergencies: call 112 in India, 911 in the United States, or your local emergency number. Do not wait for an online answer.
- No product is endorsed. MyDoctor does not recommend any brand, product or supplement in this article.
- About the sources. This article summarises, in our own words, information from the public health bodies named under Sources. Health knowledge changes, and this summary may not reflect the latest research or your personal situation.
- Liability. To the extent permitted by law, MyDoctor (MODERNUS HEALTH TECHNOLOGIES PRIVATE LIMITED) accepts no liability for any decision made on the basis of this content.
Sources
- NIDDK (NIH). Continuous Glucose Monitoring www.niddk.nih.gov
- NIDDK (NIH). Managing Diabetes www.niddk.nih.gov
- NHS. Living with type 1 diabetes www.nhs.uk

Dr. Ambed Mishra, PharmD, PhD
- Clinical Research
- Psychiatry
- Community Medicine
- Clinical Pharmacy
- Electronic Health Records
- Patient Outcomes Research
MyDoctor by MODERN US HEALTH, Austin, Texas. Ahmedabad, Gujarat. Bangalore, India.
Dr. Ambed Mishra is a clinical (patient care) scientist, author and former professor. He is Group CEO and Chief Medical Officer of MODERN US HEALTH (MODERN US GROUP), Austin, Texas, the group behind MyDoctor, and a senior consultant who teaches and trains MD/DO physicians, PharmD and PhD professionals, nurses and other healthcare professionals in patient care in the United States and India.
More about Dr. Ambed Mishra
- More than ten years of full-time leadership in United States healthcare, building patient care services that improve medication adherence and bring doctors, pharmacists and nurses together around each patient.
- Leads the MD and engineering teams behind MyDoctor: clinic and hospital management software, electronic health records and telehealth for hospitals and physician groups in the United States and India.
- Former Assistant Professor and Clinical Preceptor at Rajiv Gandhi University of Health Sciences, Bangalore, and senior researcher with hospitals, universities and patient care groups in India and the United States.
- More than 30 published research and review articles and case reports, and more than 15 international conference presentations in India, Australia, Canada, the United States, Spain and other countries.
- Chief Medical Officer and Global Program Head of a nonprofit mission that helps cover hospital and doctor visit bills for patients in need in India, Nepal, the United States and other countries.
The author's office answers questions about articles, research, speaking and collaboration. It cannot give personal medical advice.